ロード中...
Target HER four in breast cancer?
The HER4 receptor tyrosine kinase is known to have promiscuous activity in malignant cells, last but not least in breast cancer. Evidently, the prognostic and predictive impact of HER4 expression depends on the expression of different receptor isotypes, the way of receptor activation (ligand depende...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6516717/ https://ncbi.nlm.nih.gov/pubmed/31139328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26867 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|